- Home
- BRLT vs NNVC Comparison
BRLT vs NNVC Comparison
Compare BRLT & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRLT
- NNVC
- Stock Information
- Founded
- BRLT 2005
- NNVC 2005
- Country
- BRLT United States
- NNVC United States
- Employees
- BRLT N/A
- NNVC N/A
- Industry
- BRLT Consumer Specialties
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- BRLT Consumer Discretionary
- NNVC Health Care
- Exchange
- BRLT Nasdaq
- NNVC Nasdaq
- Market Cap
- BRLT 19.8M
- NNVC 22.5M
- IPO Year
- BRLT 2021
- NNVC N/A
- Fundamental
- Price
- BRLT $2.36
- NNVC $1.44
- Analyst Decision
- BRLT Hold
- NNVC
- Analyst Count
- BRLT 2
- NNVC 0
- Target Price
- BRLT $1.80
- NNVC N/A
- AVG Volume (30 Days)
- BRLT 306.9K
- NNVC 121.7K
- Earning Date
- BRLT 11-06-2025
- NNVC 11-13-2025
- Dividend Yield
- BRLT 10.50%
- NNVC N/A
- EPS Growth
- BRLT N/A
- NNVC N/A
- EPS
- BRLT N/A
- NNVC N/A
- Revenue
- BRLT $422,218,000.00
- NNVC N/A
- Revenue This Year
- BRLT $5.55
- NNVC N/A
- Revenue Next Year
- BRLT $3.88
- NNVC N/A
- P/E Ratio
- BRLT N/A
- NNVC N/A
- Revenue Growth
- BRLT N/A
- NNVC N/A
- 52 Week Low
- BRLT $1.25
- NNVC $0.94
- 52 Week High
- BRLT $3.10
- NNVC $1.92
- Technical
- Relative Strength Index (RSI)
- BRLT 49.28
- NNVC 47.45
- Support Level
- BRLT $2.75
- NNVC $1.42
- Resistance Level
- BRLT $2.70
- NNVC $1.50
- Average True Range (ATR)
- BRLT 0.28
- NNVC 0.06
- MACD
- BRLT -0.07
- NNVC 0.01
- Stochastic Oscillator
- BRLT 26.00
- NNVC 60.13
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.